Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
New Enterprise Associates
MedTech
Urinary incontinence neuromod newcomer Amber nets $100M
The University of Oxford spinout's series A round follows up on positive preliminary data from a first-in-human trial earlier this year.
Conor Hale
Jun 10, 2024 4:40pm
Mini heart pump maker Magenta Medical collects $55M
May 3, 2023 8:00am
Korro Bio rings in new year with $116M for OPERA RNA editing
Jan 5, 2022 7:30am
Gene therapy startup bursts forth from J&J and F-Prime incubator
Dec 3, 2021 8:25am
Music to its ears: Tune bags $40M to alter gene expression
Dec 2, 2021 6:00am
Shape Therapeutics reels in $112M to spur RNA editing tech
Jul 15, 2021 10:50am
